risk sharing scheme

Views & Analysis

As a pioneering risk sharing scheme has shown, new medications can be the catalyst for a whole new care infrastructure.

Oncology

Luke Piggot, a principal scientist at Debiopharm, shares some recent data and news about the company's work in DNA damage repair inhibitors.

Digital

A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.